Cerami A. Antibodies to cachectin/tumor necrosis factor reduce
interleukin-β and interleukin-6 appearance during lethal bacteremia. J Exp Med 170: 1627–1633, 1989.
French RA, VanHoy RW, Chizzonite R, Zachary JF, Dantzer
R, Parnet P, Bluthe ́ RM, and Kelley KW. Expression and
localisation of p80 and p68 interleukin-1 receptor proteins in the
brain of adult mice. J Neuroimmunol 93: 194–202, 1999.
Gabellec MA, Griffais R, Fillion G, and Haour F. Expression
of interleukin-1α, interleukin-1β and interleukin-1 receptor an-tagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Mol Brain Res 31: 122–130, 1995.
Gabellec MA, Mehrnaz J-T, Griffais R, and Haour F. Interleukin-1 receptor accessory protein transcripts in the brain and
spleen: kinetics after peripheral administration of bacterial
lipopolysaccharide in mice. Neuroimmunomodulation 3: 304–
309, 1996.
Gotschall PE, Tatsuno I, and Arimura A. Regulation of
interleukin-6 (IL-6) secretion in primary cultured rat astrocytes:
synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase
activating polypeptide (PACAP). Brain Res 637: 197–203, 1994.
Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite
RA, and Ju G. Molecular cloning and characterization of a
second subunit of the interleukin-1 receptor complex. J Biol
Chem 270: 13757–13765, 1995.
Horan MA, Little RA, Rothwell NJ, and Strijbos PJ. Comparison of the effects of several endotoxin preparations on body
temperature and metabolic rate in the rat. Can J Physiol
Pharmacol 67: 1011–1014, 1989.
Hori T, Katafuchi T, Take S, and Shimizu N. Neuroimmunomodulatory actions of hypothalamic interferon-α. Neuroimmunomodulation 5: 172–177, 1998.
Ilyin SE and Plata-Salaman CR. In vivo regulation of the
IL-1β system (ligand, receptors I and II, receptor accessory
protein, and receptor antagonist) and TNF-α mRNAs in specific
brain regions. Biochem Biophys Res Commun 227: 861–867,
1997.
Jansky L, Vybiral S, Pospisilova D, Roth J, Dornand J,
Zeisberger E, and Kaminkova J. Production of systemic and
hypothalamic cytokines during the early phase of endotoxin
fever. Neuroendocrinology 62: 55–61, 1995.
Kent S, Bluthe R-M, Kelley KW, and Dantzer R. Sickness
behavior as a new target for drug development. Trends Neurosci
13: 24–28, 1992.
Kent S, Bret-Dibat JL, Kelley KW, and Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior.
Neurosci Biobehav Rev 20: 171–175, 1996.
Kent S, Rodriguez F, Kelley KW, and Dantzer R. Reduction
in food and water intake induced by microinjection of interleukin-1β in the ventromedial hypothalamus of the rat. Physiol
Behav 56: 1031–1036, 1994.
Laye ́ S, Bluthe ́ RM, Kent S, Combe C, Me ́ dina C, Parnet P,
Kelley K, and Dantzer R. Subdiaphragmatic vagotomy blocks
induction of IL-1β mRNA in mice brain in response to peripheral
LPS. Am J Physiol Regulatory Integrative Comp Physiol 268:
R1327–R1331, 1995.
Laye ́ S, Parnet P, Goujon E, and Dantzer R. Peripheral
administration of lipopolysaccharide induces the expression of
cytokine transcripts in the brain and pituitary of mice. Mol Brain
Res 27: 157–162, 1994.
Luheshi G, Miller AJ, Brouwer S, Dascombe MJ, Rothwell
NJ, and Hopkins SJ. Interleukin-1 receptor antagonist inhibits
endotoxin fever and systemic interleukin-6 induction in the rat.
Am J Physiol Endocrinol Metab 270: E91–E95, 1996.
Opp M and Krueger JM. Interleukin-1 receptor antagonist
blocks IL-1-induced sleep and fever. Am J Physiol Regulatory
Integrative Comp Physiol 260: R453–R457, 1991.
Plata-Salaman CR. Cytokines and feeding suppression: an
integrative view from neurologic to molecular levels. Nutrition
11: 674–677, 1995.
Plata-Salaman CR and French-Mullen JM. Intracerebroventricular administration of a specific IL-1 receptor antagonist
blocks food and water intake suppression induced by interleukin-1β. Physiol Behav 51: 1277–1279, 1992.
Plata-Salaman CR, Oomura Y, and Kai Y. Tumor necrosis
factor and interleukin-1β: suppression of food intake by direct
